Fang Wang

ORCID: 0000-0002-7350-5443
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Treatment and Research
  • Management of metastatic bone disease
  • Healthcare and Venom Research
  • Prostate Cancer Diagnosis and Treatment
  • Sexual function and dysfunction studies
  • Advanced Radiotherapy Techniques
  • Urinary Bladder and Prostate Research
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment

Sichuan University
2022-2023

West China Hospital of Sichuan University
2023

Objective: To observe the therapeutic effect of mild moxibustion on preventing and treating bladder spasms after transurethral resection prostate. Method: The control group patients were given routine perioperative care, while experimental Taixi, Zhongji, Qihai, Shenque points in addition to care. Result: frequency spasms, degree pain, significantly better than those group, differences statistically significant (P<0.05). Conclusion: Mild is safe reliable

10.6913/mrhk.060203 article EN Medical Research 2024-06-30

This pilot study aimed to explore the preliminary effects and safety of stereotactic body radiotherapy (SBRT) combined with preventive pelvic primary gross tumor volumes (GTVp) boost in patients high-risk prostate cancer based on multiparameter magnetic resonance image (mpMRI). Tumors were contoured as GTVp mpMRI. The proximal seminal vesicles considered clinical target volume1. lymphatic drainage area constituted volume 2. Radiation doses 40Gy or 45Gy/5fractions planning tumor, 37.5Gy/5f...

10.1097/md.0000000000035260 article EN cc-by-nc Medicine 2023-09-29

The purpose of this study was to retrospectively review the outcomes patients with high-risk endometrial cancer treated adjuvant radiotherapy concurrent paclitaxel and cisplatin (TP).Patients who underwent radical surgery were screened between Jan 2005 Dec 2018. Patients factors received chemoradiotherapy included in study. High risks stage I, endometrioid-type grade 3 deep myometrial invasion or lymphovascular space (or both), II IVa, I III serous clear cell histology. treatment regimen one...

10.1155/2022/4621240 article EN Journal of Oncology 2022-10-11
Coming Soon ...